Skip to content

  • About CRIS
  • Search
    • Basic Search
    • Advanced Search
    • Search by Topics
      • Condition(s)/Problem(s)
      • Intervention Type
      • Phase
    • Recently Registered
    • Recently Updated
  • FAQ
  • Statistics
  • Registration Data Set

Contact Us


  •   Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
No.Overall StatusScientific Title
First subject enrolled prior to CRIS registration 130 Completed A Phase 1, Open-label, Multi-Center, to investigate Safety, Efficacy, and Pharmacokinetics (PK) of PGA40 in Previously Treated Subjects with Severe Hemophilia A
First subject enrolled prior to CRIS registration 129 Completed A multi-center, multi-national, double-blind, randomized, active-controlled, parallel-group clinical study to assess safety and efficacy of PDA10 (epoetin-alfa) compared to Eprex® in patients with anemia of chronic renal failure
        128 Not yet recruiting A multinational, open-label, randomised, controlled trial to investigate efficacy and safety of NNC0365-3769 (Mim8) in adults and adolescents with haemophilia A with or without inhibitors.
        127 Not yet recruiting Phase 2 study of Daratumumab in combination with bortezomib and dexamethasone in newly diagnosed multiple myeloma
        126 Not yet recruiting A multicenter, open, rnadomized, phase I/II clinical trial toevaluate the safety and efficacy of combined maintenance of rituximab and cytokine-induced killer cells in elderly high-risk DLBCL(Diffuse Large B-cell Lymphoma) patients responding to the first...
First subject enrolled prior to CRIS registration 125 Completed A Single and Multiple Ascending Dose Phase 1 Clinical Trial to Evaluate Pharmacodynamic biomarker of JAK inhibitor in Healthy Male Subjects
        124 Not yet recruiting Phase II, single-arm trial of carfilzomib, lenalidomide, and dexamethasone re-induction followed by the 2nd ASCT in multiple myeloma patients relapsed after the 1st ASCT
        123 Not yet recruiting Multicenter, investigator initiated trial, investigating the efficacy and safety of IV-immunoglobulin therapy in elderly patients with diffuse large B cell lymphoma treated with R-CHOP
        122 Not yet recruiting Brentuximab vedotin plus cisplatin, cytarabine, and dexamethasone in patients with relapsed or refractory Hodgkin’s lymphoma who are eligible for transplant
First subject enrolled prior to CRIS registration 121 Not yet recruiting A randomized, prospective, comparative study of the effectiveness of prophylactic entecavir treatment for HBV reactivation in past HBV infected patients with hematopoietic stem cell transplantation
  •    12345678910  다음으로이동 마지막으로이동